Qana Therapeutics Inc.

Austin, TX Doing business as Qana Therapeutics Inc.

UEI
UN49C5DAR8E8
CAGE
834V3
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
4305 Avenue D, Austin, TX 78751, USA
Website
qanatx.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Qana Therapeutics Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir concept award "therapeutics" - targeted delivery of ferroptosis inducers for treatment of adrenocortical carcinoma Contract · 75N91024C00008 National Cancer Institute $354,672

Quick answers

What is Qana Therapeutics Inc.'s UEI?

Qana Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is UN49C5DAR8E8.

What is Qana Therapeutics Inc.'s CAGE code?

Qana Therapeutics Inc.'s CAGE code is 834V3.

What is Qana Therapeutics Inc.'s primary NAICS code?

Qana Therapeutics Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).

Where is Qana Therapeutics Inc. located?

Qana Therapeutics Inc.'s physical address in SAM.gov is 4305 Avenue D, Austin, TX 78751, USA.

Is Qana Therapeutics Inc. registered in SAM.gov?

Yes. Qana Therapeutics Inc.'s SAM.gov registration is active through February 10, 2027.

What is Qana Therapeutics Inc.'s most recent federal award?

Qana Therapeutics Inc.'s most recent federal contract award is Sbir concept award "therapeutics" - targeted delivery of ferroptosis inducers for treatment of adrenocortical carcinoma (75N91024C00008), from National Cancer Institute, on February 15, 2024.

On GovTribe

See Qana Therapeutics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login